Condes

78 / 116

786
1. Peter Kopp, Juan Carlos Solis-S. Thyroid Hormone Synthesis,
editado por Wondisford F., Radovick S.Clinical management
of thyroid disease, 1° edición, Philadelphia, Saunders Elsevier
2009, págs 19-41.
2. Stathatos N. Thyroid physiology. Med Clin North Am.
2012;96:165-73.
3. Steven I Sherman. The Laboratory Approach to Thyroid Disorders,
editado por David S. Cooper. Medical management of thyroid
diseases, 2° edición, New York, Informa Healthcare USA, Inc.
2008. págs 1-38.
4. Baloch Z, Carayon P, Conte-Devolx B et al. Laboratory medicine
practice guidelines. Laboratory support for the diagnosis and
monitoring of thyroid disease. Thyroid. 2003;13:3-126.
5. Garber JR, Cobin RH, Gharib H et al. Clinical practice guidelines
for hypothyroidism in adults: cosponsored by the American
Association of Clinical Endocrinologists and the American
Thyroid Association. Thyroid. 2012;22:1200-35.
6. Dufour DR. Laboratory tests of thyroid function: uses and
limitations. Endocrinol Metab Clin North Am. 2007; 36:579-
94.
7. De Groot L, Abalovich M, Alexander EK. Management of thyroid
dysfunction during pregnancy and postpartum: an Endocrine
Society clinical practice guideline. J Clin Endocrinol Metab.
2012;97:2543-65.
8. Bahn Chair RS, Burch HB, Cooper DS et al.Hyperthyroidism
and other causes of thyrotoxicosis: management guidelines of
the American Thyroid Association and American Association of
Clinical Endocrinologists. Thyroid. 2011;21:593-646.
9. Nieman LK, Biller BM, Findling JW et al. The diagnosis of Cushing’s
syndrome: an Endocrine Society Clinical Practice Guideline. J
Clin Endocrinol Metab. 2008;93:1526-40.
10. Turpeinen U, Hämäläinen E. Determination of cortisol in
serum, saliva and urine. Best Pract Res Clin Endocrinol Metab.
2013;27:795-801.
11. Raff H, Auchus RJ, Findling JW et al. Urine free cortisol in the
diagnosis of Cushing’s syndrome: is it worth doing and, if so, how?
J Clin Endocrinol Metab. 2015;100:395-7.
12. Bancos I, Hahner S, Tomlinson J et al. Diagnosis and management
of adrenal insufficiency. Lancet Diabetes Endocrinol.
2015;3:216-26.
13. Crowley RK1, Argese N, Tomlinson JW et al. Central
hypoadrenalism. J Clin Endocrinol Metab. 2014:99; 4027-36.
14. Charmandari E, Nicolaides NC, Chrousos GP. Adrenal
insufficiency. Lancet. 2014;383:2152-67.
15. Bhasin S, Basaria S. Diagnosis and treatment of hypogonadism
in men. Best Pract Res Clin Endocrinol Metab. 2011;25:251-70
16. Nieschlag E. Current topics in testosterone replacement of
REFERENCIAS BIBLIOGRáFICAS
hypogonadal men. Best Pract Res Clin Endocrinol Metab.
2015;29:77-90.
17. Rothman MS, Wierman ME. Female hypogonadism: evaluation
of the hypothalamic-pituitary-ovarian axis. Pituitary.
2008;11:163-9.
18. Visser JA, Schipper I, Laven JS et al. Anti-Müllerian hormone: an
ovarian reserve marker in primary ovarian insufficiency. Nat Rev
Endocrinol. 2012;8:331-41.
19. Molitch ME, Clemmons DR, Malozowski S et al. Evaluation and
treatment of adult growth hormone deficiency: an endocrine
society clinical practice guideline. J Clin Endocrinol Metab
2011;96:1587-1609
20. Cook DM, Yuen KC, Biller BM et al. American Association of
Clinical Endocrinologists medical guidelines for clinical practice
for growth hormone use in growth hormone-deficient adults and
transition patients - 2009 update. Endocr Pract; Suppl 2:1-29
21. Kannan S, Kennedy L. Diagnosis of acromegaly: state of the art.
Expert Opin Med Diagn. 2013;7:443-53
22. Katznelson L1, Laws ER Jr, Melmed S et al. Acromegaly: an
endocrine society clinical practice guideline. J Clin Endocrinol
Metab. 2014;99:3933-51.
23. Romijn JA. Hyperprolactinemia and prolactinoma. Handb Clin
Neurol. 2014;124:185-95
24. Melmed S, Casanueva FF, Hoffman AR et al. Diagnosis and
treatment of hyperprolactinemia: an Endocrine Society clinical
practice guideline. J Clin Endocrinol Metab. 2011;96:273-88.
25. Glezer A, Bronstein MD. Prolactinomas. Endocrinol Metab Clin
North Am. 2015;44:71-8
26. do Carmo Dias Gontijo M, de Souza Vasconcellos L, Ribeiro-
Oliveira A Jr. Hook effect and linear range in prolactin assays:
distinct confounding entities. Pituitary. 2015 Jan 11. [Epub
ahead of print]
27. Bernard V, Young J, Chanson P et al. New insights in prolactin:
pathological implications. Nat Rev Endocrinol. 2015;11:265-
75.
28. Fahie-Wilson M, Smith TP. Determination of prolactin: the
macroprolactin problem. Best Pract Res Clin Endocrinol Metab.
2013;27:725-42
29. Mulatero P, Stowasser M, Loh KC et al. Increased diagnosis
of primary aldosteronism, including surgically correctable
forms, in centers from five continents.J Clin Endocrinol Metab
2004;89:1045–50.
30. Funder JW, Carey RM, Fardella C et al. Case detection, diagnosis,
and treatment of patients with primary aldosteronism: an
Endocrine Society clinical practice guideline. J Clin Endocrinol
Metab 2008;93:3266–81.
31. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L,
[REV. MED. CLIN. CONDES - 2015; 26(6) 776-787]